IMPACT SCORE JOURNAL RANKING CONFERENCE RANKING Conferences Journals Workshops Seminars SYMPOSIUMS MEETINGS BLOG LaTeX 5G Tutorial Free Tools

Search About Journals, Conferences, and Book Series

Multiple Sclerosis and Related Disorders

Impact, Factor and Metrics, Impact Score, Ranking, h-index, SJR, Rating, Publisher, ISSN, and More

Last Updated on October 31, 2023

Impact Score

2022-2023

3.26

h-Index

2022-2023

 55

Rank

2022-2023

 4818

SJR

2022-2023

 0.920

Note: The impact score or impact index shown here is equivalent to the average number of times documents published in a journal/conference in the past two years have been cited in the current year (i.e., Cites / Doc. (2 years)). It is based on Scopus data and can be a little higher or different compared to the impact factor (IF) produced by Journal Citation Report. Please refer to the Web of Science data source to check the exact journal impact factor ™ (Thomson Reuters) metric.

Important Metrics and Factor

Title Multiple Sclerosis and Related Disorders
Abbreviation Mult. Scler. Relat. Disord.
Publication Type Journal
Subject Area, Categories, Scope Medicine (miscellaneous) (Q1); Neurology (Q2); Neurology (clinical) (Q2)
h-index 55
Overall Rank/Ranking 4818
SCImago Journal Rank (SJR) 0.920
Impact Score 3.26
Publisher Elsevier
Country United States
ISSN 22110356, 22110348
Best Quartile Q1
Coverage History 2012-2022




About Multiple Sclerosis and Related Disorders


Multiple Sclerosis and Related Disorders is a journal covering the technologies/fields/categories related to Medicine (miscellaneous) (Q1); Neurology (Q2); Neurology (clinical) (Q2). It is published by Elsevier. The overall rank of Multiple Sclerosis and Related Disorders is 4818. According to SCImago Journal Rank (SJR), this journal is ranked 0.920. SCImago Journal Rank is an indicator, which measures the scientific influence of journals. It considers the number of citations received by a journal and the importance of the journals from where these citations come. SJR acts as an alternative to the Journal Impact Factor (or an average number of citations received in last 2 years). This journal has an h-index of 55. The best quartile for this journal is Q1.

The ISSN of Multiple Sclerosis and Related Disorders journal is 22110356, 22110348. An International Standard Serial Number (ISSN) is a unique code of 8 digits. It is used for the recognition of journals, newspapers, periodicals, and magazines in all kind of forms, be it print-media or electronic. Multiple Sclerosis and Related Disorders is cited by a total of 5764 articles during the last 3 years (Preceding 2022).


Multiple Sclerosis and Related Disorders Impact IF 2022-2023


The Impact IF 2022 of Multiple Sclerosis and Related Disorders is 3.26, which is computed in 2023 as per its definition. Multiple Sclerosis and Related Disorders IF is decreased by a factor of 0.36 and approximate percentage change is -9.94% when compared to preceding year 2021, which shows a falling trend. The impact IF, also denoted as Journal impact score (JIS), of an academic journal is a measure of the yearly average number of citations to recent articles published in that journal. It is based on Scopus data.

Table Setting

Multiple Sclerosis and Related Disorders Impact IF 2023 Prediction


Impact IF 2022 of Multiple Sclerosis and Related Disorders is 3.26. If the same downward trend persists, Impact IF may fall in 2023 as well.


Impact IF Trend


Year wise Impact IF of Multiple Sclerosis and Related Disorders. Based on Scopus data.


Year Impact IF
2023/2024 Coming Soon
2022 3.26
2021 3.62
2020 2.94
2019 2.46
2018 2.45
2017 2.98
2016 2.37
2015 1.21
2014 1.04

Multiple Sclerosis and Related Disorders h-index


  Table Setting

Multiple Sclerosis and Related Disorders has an h-index of 55. It means 55 articles of this journal have more than 55 number of citations. The h-index is a way of measuring the productivity and citation impact of the publications. The h-index is defined as the maximum value of h such that the given journal/author has published h papers that have each been cited at least h number of times.




Multiple Sclerosis and Related Disorders ISSN


The ISSN of Multiple Sclerosis and Related Disorders is 22110356, 22110348. ISSN stands for International Standard Serial Number.

An ISSN is a unique code of 8 digits. It is used for the recognition of journals, newspapers, periodicals, and magazines in all kind of forms, be it print-media or electronic.

Table Setting

Multiple Sclerosis and Related Disorders Rank and SCImago Journal Rank (SJR)


The overall rank of Multiple Sclerosis and Related Disorders is 4818. According to SCImago Journal Rank (SJR), this journal is ranked 0.920. SCImago Journal Rank is an indicator, which measures the scientific influence of journals. It considers the number of citations received by a journal and the importance of the journals from where these citations come.

SJR of Multiple Sclerosis and Related Disorders by Year


Year SJR
2023/2024 Coming Soon
2022 0.920
2021 1.006
2020 0.870
2019 0.829
2018 1.079
2017 1.123
2016 0.961
2015 0.624
2014 0.511

Ranking of Multiple Sclerosis and Related Disorders by Year


Year Ranking
2023/2024 Coming Soon
2022 4818
2021 4075
2020 5364
2019 5667
2018 3887
2017 3708
2016 4672
2015 7611
2014 8808

Multiple Sclerosis and Related Disorders Publisher


Table Setting

Multiple Sclerosis and Related Disorders is published by Elsevier. It's publishing house is located in United States. Coverage history of this journal is as following: 2012-2022. The organization or individual who handles the printing and distribution of printed or digital publications is known as Publisher.


Call For Papers


Visit the official website of the journal/conference to check the further details about the call for papers.


Abbreviation


The IS0 4 standard abbreviation of Multiple Sclerosis and Related Disorders is Mult. Scler. Relat. Disord.. This abbreviation ('Mult. Scler. Relat. Disord.') is well recommended and approved for the purpose of indexing, abstraction, referencing and citing goals. It meets all the essential criteria of ISO 4 standard.

ISO 4 (International Organization for Standardization 4) is an international standard that defines a uniform and consistent system for abbreviating serial publication titles and journals.


How to publish in Multiple Sclerosis and Related Disorders


If your research field is/are related to Medicine (miscellaneous) (Q1); Neurology (Q2); Neurology (clinical) (Q2), then please visit the official website of this journal.


Acceptance Rate


The acceptance rate/percentage of any academic journal/conference depends upon many parameters. Some of the critical parameters are listed below.

  • The demand or interest of researchers/scientists in publishing in a specific Journal/Conference.
  • Peer review complexity and timeline.
  • The mix of unsolicited and invited submissions.
  • The time it takes from manuscript submission to final publication.
  • And Many More.

It is essential to understand that the acceptance rate/rejection rate of papers varies among journals. Some Journals considers all the manuscripts submissions as a basis of acceptance rate computation. On the other hand, few consider the only manuscripts sent for peer review or few even not bother about the accurate maintenance of total submissions. Hence, it can provide a rough estimation only.

The best way to find out the acceptance rate is to reach out to the associated editor or to check the official website of the Journal/Conference.



Frequently Asked Questions (FAQs)


What's the latest impact IF of the Multiple Sclerosis and Related Disorders?

Multiple Sclerosis and Related Disorders latest impact IF is 3.26. It's evaluated in the year 2022. The highest and the lowest impact IF or impact score of this journal are 3.62 (2021) and 1.04 (2014), respectively, in the last 9 years. Moreover, its average IS is 2.48 in the previous 9 years.


What's the SCImago Journal Rank (SJR) of the Multiple Sclerosis and Related Disorders?

The Multiple Sclerosis and Related Disorders has an SJR (SCImago Journal Rank) of 0.920, according to the latest data. It is computed in the year 2023. In the past 9 years, this journal has recorded a range of SJR, with the highest being 1.123 in 2017 and the lowest being 0.511 in 2014. Furthermore, the average SJR of the Multiple Sclerosis and Related Disorders over the previous 9-year period stands at 2.48.


What's the latest h-index of the Multiple Sclerosis and Related Disorders?

The latest h-index of the Multiple Sclerosis and Related Disorders is 55.


Who's the publisher of the Multiple Sclerosis and Related Disorders?

The Multiple Sclerosis and Related Disorders is published by the Elsevier, with its country of publication being the United States.


What's the current ranking of the Multiple Sclerosis and Related Disorders?

The Multiple Sclerosis and Related Disorders is currently ranked 4818 out of 27955 Journals, Conferences, and Book Series in the latest ranking. Over the course of the last 9 years, this journal has experienced varying rankings, reaching its highest position of 3708 in 2017 and its lowest position of 8808 in 2014.


What's the abbreviation or short name for the Multiple Sclerosis and Related Disorders?

The standard ISO4 abbreviation for the Multiple Sclerosis and Related Disorders is Mult. Scler. Relat. Disord..


Is the "Multiple Sclerosis and Related Disorders" classified as a Journal, Conference and Proceedings, Trade Journal or Book Series?

Multiple Sclerosis and Related Disorders is classified as a journal that the Elsevier publishes.


What's the scope or major areas of the Multiple Sclerosis and Related Disorders?

The Multiple Sclerosis and Related Disorders encompasses the following areas:

  • Medicine (miscellaneous)
  • Neurology
  • Neurology (clinical)

For a more comprehensive understanding of its scope, check the official website of this journal.


What's the ISSN of the Multiple Sclerosis and Related Disorders?

The Multiple Sclerosis and Related Disorders is assigned the following International Standard Serial Numbers (ISSN): 22110356, 22110348.


What's the best quartile of the Multiple Sclerosis and Related Disorders?

The best quartile for the Multiple Sclerosis and Related Disorders is Q1 (2022).


What's the coverage history of the Multiple Sclerosis and Related Disorders?

The Multiple Sclerosis and Related Disorders coverage history can be summarized as follows: 2012-2022.


Credits and Sources


  • Scimago Journal & Country Rank (SJR), https://www.scimagojr.com/
  • Journal Impact Factor, https://clarivate.com/



Impact Score, h-Index, and Other Important Details of These Journals, Conferences, and Books


Journal/Conference/Workshop/Book Title Type Ranking Publisher h-index Impact Score
Journal of Geriatric Physical Therapy journal 5578 Lippincott Williams and Wilkins Ltd. 43 1.80
Journal of Applied Business Research journal 23890 29 0.28
Air and Space Power Journal (discontinued) journal 28397 AU Press 9 0.20
World Englishes journal 4960 Wiley-Blackwell 60 1.97
International Journal of Parallel, Emergent and Distributed Systems journal 15843 Taylor and Francis Ltd. 23 1.28
Syntax journal 3422 Wiley-Blackwell Publishing Ltd 29 0.93
Howard Journal of Communications journal 9564 Taylor and Francis Ltd. 36 1.66
Educational Measurement: Issues and Practice journal 4494 Wiley-Blackwell Publishing Ltd 59 1.53
Tekstilec trade journal 19217 Faculty of Natural Sciences and Engineering, Tekstilec 14 0.73
Sapporo Medical Journal journal 20468 Cancer Research Institute, Sapporo Medical University 3 0.00

Check complete list




Year wise Impact Score (IS) of Multiple Sclerosis and Related Disorders

Impact Score Table

Year Impact Score (IS)
2023/2024 Coming Soon
2022 3.26
2021 3.62
2020 2.94
2019 2.46
2018 2.45
2017 2.98
2016 2.37
2015 1.21
2014 1.04



Top Journals/Conferences in Medicine (miscellaneous)

New England Journal of Medicine
Massachussetts Medical Society | United States

Nature Medicine
Nature Publishing Group | United Kingdom

MMWR Recommendations and Reports
Centers for Disease Control and Prevention (CDC) | United States

Nature Reviews Drug Discovery
Nature Publishing Group | United Kingdom

Nature Reviews Immunology
Nature Publishing Group | United Kingdom

Morbidity and Mortality Weekly Report
Department of Health and Human Services | United States

Lancet, The
Elsevier Ltd. | United Kingdom

Physiological Reviews
American Physiological Society | United States

MMWR supplements
Epidemiology Program Office | United States

Annals of Oncology
Elsevier Ltd. | United Kingdom

See All

Top Journals/Conferences in Neurology

Lancet Neurology, The
Elsevier Ltd. | United Kingdom

JAMA Neurology
American Medical Association | United States

Nature Reviews Neurology
Nature Publishing Group | United Kingdom

Molecular Neurodegeneration
BioMed Central Ltd. | United Kingdom

Acta Neuropathologica
Springer Verlag | Germany

Neuro-Oncology
Oxford University Press | United Kingdom

Brain
Oxford University Press | United Kingdom

Annals of Neurology
John Wiley & Sons Inc. | United States

Alzheimer's and Dementia
John Wiley & Sons Inc. | United States

Journal of Neurology, Neurosurgery and Psychiatry
BMJ Publishing Group | United Kingdom

See All

Top Journals/Conferences in Neurology (clinical)

Lancet Neurology, The
Elsevier Ltd. | United Kingdom

JAMA Neurology
American Medical Association | United States

Nature Reviews Neurology
Nature Publishing Group | United Kingdom

Molecular Neurodegeneration
BioMed Central Ltd. | United Kingdom

Acta Neuropathologica
Springer Verlag | Germany

Neuro-Oncology
Oxford University Press | United Kingdom

Brain
Oxford University Press | United Kingdom

Annals of Neurology
John Wiley & Sons Inc. | United States

Alzheimer's and Dementia
John Wiley & Sons Inc. | United States

Journal of Neurology, Neurosurgery and Psychiatry
BMJ Publishing Group | United Kingdom

See All